Sales continue to significantly increase

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com






FOR PUBLIC RELEASE


NZX Limited
Wellington

12 December 2024


Sales continue to significantly increase

As we approach the half-year mark, we can report strong momentum in our sales
performance across our key markets. Our revenue is forecast to exceed $600,000
(unaudited) for the six-month period, and we expect to have unaudited sales of
approximately $400,000 for the October to December quarter. This will be
approximately 80% growth quarter-on-quarter.

This significant growth reflects our increased presence in both domestic and
international markets.




45
223
400
ACTUAL
Q4 FY24
Apr - Jun
ACTUAL
Q1 FY25
Jul - Sep
FORECAST
Q2 FY25
Oct - Dec
MARKET UPDATE

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com


Germany

We continue to expand our product portfolio in this market, with the launch of a new
product in December. This reinforces our position in Europe’s largest medicinal cannabis
market, with increased sales expected over the coming months.

Australia

Our sales in this large but competitive market are steadily growing, with our distribution
channels and product portfolio now firmly established. We continue to foster key
partnerships and remain committed to growing sales in this key market.

New Zealand

Locally, we have released an additional dried flower product now available to patients.
Sales month on month continue to increase, with highest sales reported for the month of
December following from the release of this new product. In addition, we have new
products currently being assessed by the NZ Ministry of Health.

United Kingdom

We have successfully launched three oil products in December and these products are
now available to patients and prescribers via our distribution partner, Target
Health. Over the coming months we will continue to be build relationships with key
clinics to build awareness of Rua in this key market.

Delivering on Strategy

These achievements highlight our focus delivering our differentiated strategy with
efficiency and focus. By leveraging our expertise in genetic development, and
international distribution, we are creating a scalable high-value intergenerational
company.


ENDS  
 

The person who authorised this announcement:

Paul Naske
Chief Executive Officer
paul.naske@ruabio.com
+64 21 445154